Ikarian Capital, LLC - Dec 31, 2024 SCHEDULE 13G Report for Traws Pharma, Inc. Common stock, par value $.01 per share (TRAW)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Traws Pharma, Inc. Common stock, par value $.01 per share
Symbol: TRAW
Shares outstanding: 3.95M shares
Disclosed Ownership: 394K shares
Ownership: 9.99%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 01:18 PM
Date of event: Dec 31, 2024
Next filing: May 15, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	9.99%	394K	0	394K	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	9.99%	394K	0	394K	/s/ Neil Shahrestani	Neil Shahrestani